Research reading
Glycosides: natural or reproduced by synthesis, other than rutoside (rutin) and its derivatives demand and the China (CHN) to SGP (SGP) lane
SGP (SGP) reported $25.4M of glycosides: natural or reproduced by synthesis, other than rutoside (rutin) and its derivatives imports in 2024. China (CHN) accounted for 15.7% of the observed market and reported $4.0M in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +20.9% buyer growth and +14.2% exporter growth. The page separates reported values from projections and indicators.
